Cite
Gelebart P, Hegazy SA, Wang P, et al. Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood Cancer J. 2012;2:e82doi: 10.1038/bcj.2012.27.
Gelebart, P., Hegazy, S. A., Wang, P., Bone, K. M., Anand, M., Sharon, D., Hitt, M., Pearson, J. D., Ingham, R. J., Ma, Y., & Lai, R. (2012). Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood cancer journal, 2e82. https://doi.org/10.1038/bcj.2012.27
Gelebart, P, et al. "Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma." Blood cancer journal vol. 2 (2012): e82. doi: https://doi.org/10.1038/bcj.2012.27
Gelebart P, Hegazy SA, Wang P, Bone KM, Anand M, Sharon D, Hitt M, Pearson JD, Ingham RJ, Ma Y, Lai R. Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood Cancer J. 2012 Aug 10;2:e82. doi: 10.1038/bcj.2012.27. PMID: 22885405; PMCID: PMC3432482.
Copy
Download .nbib